Literature DB >> 29719880

Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat.

Golbahar Saeedi1, Fereshteh Jeivad1, Mohammadhadi Goharbari1, Gholamreza Hassanzadeh Gheshlaghi2, Omid Sabzevari1,3.   

Abstract

BACKGROUND: Non-alcoholic fatty liver (NAFLD) is one the most prevalent disease worldwide which characterized by fat accumulation in liver with no established efficient therapy. We designed this study to investigate protective and therapeutic effect of Crataegus oxyacantha L. (C. oxyacantha) on NAFLD induced by high fat diet in rat models.
METHODS: NAFLD was induced by High Fat Diet+fructose (HFD), 45 Wistar rats were divided to 8 groups including control, HFD, HFD+diet change, HFD+diet change+C. oxyacantha 20 mg/kg, co treatment of HFD+C. oxyacantha 10, 20 and 40 mg/kg, and normal diet+C. oxyacantha 40 mg. C. oxyacantha was administered orally. Effectiveness of the C. oxyacantha was assessed through measuring the biochemical factors, and oxidative stress marker (FRAP, GSH, and MDA). Histopathological study was performed using H & E staining.
RESULTS: The diet change from high fat to low fat ameliorated liver damage. However, consumption of C. oxyacantha (10 & 20 mg/kg) caused significant reduction in the level of all examined liver biomarkers specially LDH, that showed C. oxyacantha can restore the hepatocyte damage due to HFD. The C. oxyacantha showed a protective effect which was more prominent in the animals treated with the 20 mg/kg C. oxyacantha. The administration of C. oxyacantha caused increased antioxidant status (GSH and FRAP levels) and decreased lipid peroxidation in treated animals. MAJOR
CONCLUSION: Accordingly, C. oxyacantha have both therapeutic and protective effect for NAFLD and may be a potential candidate for further assessments in clinical studies. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29719880     DOI: 10.1055/a-0579-7532

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  3 in total

1.  Hawthorn Herbal Preparation from Crataegus oxyacantha Attenuates In Vivo Carbon Tetrachloride -Induced Hepatic Fibrosis via Modulating Oxidative Stress and Inflammation.

Authors:  Alaaeldin Ahmed Hamza; Fawzy Mohamed Lashin; Mona Gamel; Soha Osama Hassanin; Youssef Abdalla; Amr Amin
Journal:  Antioxidants (Basel)       Date:  2020-11-24

Review 2.  Botanical, Phytochemical, Anti-Microbial and Pharmaceutical Characteristics of Hawthorn (Crataegusmonogyna Jacq.), Rosaceae.

Authors:  Federico Martinelli; Anna Perrone; Sanaz Yousefi; Alessio Papini; Stefano Castiglione; Francesco Guarino; Angela Cicatelli; Mitra Aelaei; Neda Arad; Mansour Gholami; Seyed Alireza Salami
Journal:  Molecules       Date:  2021-11-30       Impact factor: 4.411

Review 3.  Potential Roles and Key Mechanisms of Hawthorn Extract against Various Liver Diseases.

Authors:  Eujin Kim; Eungyeong Jang; Jang-Hoon Lee
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.